Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|December 13, 2017
Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenibCornelis M van Tilburg, Florian Selt, Felix Sahm, et al.
Frontiers in Oncology|February 15, 2024
Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in SwedenSofia Wallin, Ingrid Øra, Gabriela Prochazka, et al.
British Journal of Haematology|January 13, 2011
Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*Cornelis M van Tilburg, Elisabeth A M Sanders, Elisabeth E Nibbelke, et al.
JCO Precision Oncology|January 11, 2024
Precision Medicine for Childhood Cancer: Current Limitations and Future PerspectivesMartin G McCabe, Birgit Geoerger, Louis Chesler, et al.
Pediatric Blood & Cancer|July 28, 2011
Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseasesCornelis M van Tilburg, Marc B Bierings, Guy A M Berbers, et al.
Journal of Neuro-Oncology|October 2, 2023
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cellsJohanna Vollmer, Jonas Ecker, Thomas Hielscher, et al.
Clinical Pharmacology and Therapeutics|May 29, 2021
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol DevelopmentLydia Beck, Ruth Witt, Martina Nesper-Brock, et al.
Leukemia Research|November 6, 2010
Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment compositionCornelis M van Tilburg, Vincent H J van der Velden, Elisabeth A M Sanders, et al.
Pharmaceutical Medicine|May 4, 2026
Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive AnalysisLaura Fankhauser, Franca Ligas, Giovanni Lesa, et al.
Clinical Immunology (Orlando, Fla.)|December 17, 2009
Lymphocyte characteristics in children with common variable immunodeficiencyAnnick A J M van de Ven, Lisette van de Corput, Cornelis M van Tilburg, et al.
Pageof 6